Archive: 20/01/2016

Charity buys Merck vaccine to thwart Ebola comeback

Charity alliance Gavi committed to buy $5 million (4.6 million euros) worth of an experimental Ebola vaccine on Wednesday from US drugmaker Merck, enough it hopes to thwart any return of the epidemic that killed thousands.

page 3 from 9